0
20. 5. 2017.
Long term efficacy of nilotinib as front- and second-line therapy in Bosnia and Herzegovina: Real life experience.
e18549Background: In this study we examined the long-term real life clinical outcomes of patients receiving front- line nilotinib and patients who switched from branded or generic imatinib to nilot...